Nanostream intros Veloce add-on

Nanostream Inc. earlier this month rolled out a fraction collector add-on to it Veloce micro parallel liquid chromatography system. The fraction collector was developed in response to customers who were looking to take advantage of the Veloce system as a sample preparation device for mass spec applications.
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
PASADENA, Calif.—Nanostream Inc. earlier this month rolled out a fraction collector add-on to it Veloce micro parallel liquid chromatography system. The fraction collector was developed in response to customers who were looking to take advantage of the Veloce system as a sample preparation device for mass spec applications.
Continue reading below...
Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
WebinarsAdvancing predictive in vitro models
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.
Read More
"I've always believed that the way you develop a technology is to make sure the first version solves a problem and then you let customers drive you to the next thing," says Steve O'Connor, CEO and founder of Nanostream. "That is what happened here."
The fraction collector automates front-end sample preparation for researchers to help them accelerate routine assays that require MS, MS/MS or other, alternate modes of detection. The hope at Nanostream is that the Veloce system, along with the fraction collector can help drug discovery researchers move ADME to earlier in the discovery cycle.
But in order to move ADME, and specifically DMPK, to earlier in the process, there needs to be an increase in throughput. "ADME is responsible for a large portion of attrition and DMPK, especially, is a real bottleneck," says Surekha Vajjhala, director of marketing for Nanostream.
According to the company, increased throughput is created by taking separations offline. This decoupling of the chromatography from detection and quantitation allows researchers to get more "up" time from their MS instrumentation.
"There are a range of applications that can benefit from this," Vajjhala adds. "This includes drug-drug interaction studies, pharmacokinetic profiling, stability assays and others."

About the Author

Related Topics

Published In

Volume 1 - Issue 4 | June 2005

June 2005

June 2005 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue